{"entity":{"type":"insider","cik":"0001814304","url":"/insider/0001814304","json_url":"/insider/0001814304.json","name":"Lewis Karen","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":14,"first":"2023-01-25","last":"2025-01-30","span_basis":"filed_date"},"name_variants":[{"name":"Lewis Karen","source":"filing","n_filings":14,"first_seen":"2023-01-25","last_seen":"2025-01-30"}],"transactions":[{"id":4328359,"accession":"0001127602-25-002381","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-002381","line_url":"/filing/0001127602-25-002381#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001814304","owner_name":"Lewis Karen","owner_display_name":"Lewis Karen","owner_url":"/insider/0001814304","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":364.0,"shares_display":"364","price_per_share":29.5236,"price_display":"29.52","price_state":"stated","total_value":10746.5904,"total_display":"10,746.59","total_whole":"10,747","shares_owned_after":70251.0,"shares_owned_after_display":"70,251","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-29","filed_date":"2025-01-30","scope":"insider"},{"id":5130411,"accession":"0001127602-25-001839","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-001839","line_url":"/filing/0001127602-25-001839#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001814304","owner_name":"Lewis Karen","owner_display_name":"Lewis Karen","owner_url":"/insider/0001814304","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1751.0,"shares_display":"1,751","price_per_share":30.4255,"price_display":"30.43","price_state":"stated","total_value":53275.0505,"total_display":"53,275.05","total_whole":"53,275","shares_owned_after":70615.0,"shares_owned_after_display":"70,615","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-22","filed_date":"2025-01-23","scope":"insider"},{"id":4511084,"accession":"0001127602-25-001623","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-001623","line_url":"/filing/0001127602-25-001623#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001814304","owner_name":"Lewis Karen","owner_display_name":"Lewis Karen","owner_url":"/insider/0001814304","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1241.0,"shares_display":"1,241","price_per_share":29.9582,"price_display":"29.96","price_state":"stated","total_value":37178.1262,"total_display":"37,178.13","total_whole":"37,178","shares_owned_after":43858.0,"shares_owned_after_display":"43,858","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-17","filed_date":"2025-01-21","scope":"insider"},{"id":4594209,"accession":"0001127602-25-001200","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-001200","line_url":"/filing/0001127602-25-001200#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001814304","owner_name":"Lewis Karen","owner_display_name":"Lewis Karen","owner_url":"/insider/0001814304","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1599.0,"shares_display":"1,599","price_per_share":28.7021,"price_display":"28.70","price_state":"stated","total_value":45894.6579,"total_display":"45,894.66","total_whole":"45,895","shares_owned_after":45099.0,"shares_owned_after_display":"45,099","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-13","filed_date":"2025-01-14","scope":"insider"},{"id":3023767,"accession":"0001127602-24-002743","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-24-002743","line_url":"/filing/0001127602-24-002743#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001814304","owner_name":"Lewis Karen","owner_display_name":"Lewis Karen","owner_url":"/insider/0001814304","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":883.0,"shares_display":"883","price_per_share":65.53,"price_display":"65.53","price_state":"stated","total_value":57862.99,"total_display":"57,862.99","total_whole":"57,863","shares_owned_after":46387.0,"shares_owned_after_display":"46,387","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-30","filed_date":"2024-01-31","scope":"insider"},{"id":3023762,"accession":"0001127602-24-002743","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-002743","line_url":"/filing/0001127602-24-002743#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001814304","owner_name":"Lewis Karen","owner_display_name":"Lewis Karen","owner_url":"/insider/0001814304","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":367.0,"shares_display":"367","price_per_share":64.1382,"price_display":"64.14","price_state":"stated","total_value":23538.7194,"total_display":"23,538.72","total_whole":"23,539","shares_owned_after":47270.0,"shares_owned_after_display":"47,270","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-29","filed_date":"2024-01-31","scope":"insider"},{"id":2086744,"accession":"0001127602-24-002017","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-002017","line_url":"/filing/0001127602-24-002017#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001814304","owner_name":"Lewis Karen","owner_display_name":"Lewis Karen","owner_url":"/insider/0001814304","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4286.0,"shares_display":"4,286","price_per_share":63.69,"price_display":"63.69","price_state":"stated","total_value":272975.34,"total_display":"272,975.34","total_whole":"272,975","shares_owned_after":47637.0,"shares_owned_after_display":"47,637","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-23","filed_date":"2024-01-24","scope":"insider"},{"id":2345733,"accession":"0001127602-24-001949","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-001949","line_url":"/filing/0001127602-24-001949#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001814304","owner_name":"Lewis Karen","owner_display_name":"Lewis Karen","owner_url":"/insider/0001814304","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1738.0,"shares_display":"1,738","price_per_share":64.996,"price_display":"65.00","price_state":"stated","total_value":112963.048,"total_display":"112,963.05","total_whole":"112,963","shares_owned_after":51923.0,"shares_owned_after_display":"51,923","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-22","filed_date":"2024-01-23","scope":"insider"},{"id":3023582,"accession":"0001127602-24-001601","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-001601","line_url":"/filing/0001127602-24-001601#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001814304","owner_name":"Lewis Karen","owner_display_name":"Lewis Karen","owner_url":"/insider/0001814304","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3276.0,"shares_display":"3,276","price_per_share":65.58,"price_display":"65.58","price_state":"stated","total_value":214840.08,"total_display":"214,840.08","total_whole":"214,840","shares_owned_after":53661.0,"shares_owned_after_display":"53,661","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-17","filed_date":"2024-01-18","scope":"insider"},{"id":2148024,"accession":"0001127602-24-001440","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-24-001440","line_url":"/filing/0001127602-24-001440#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001814304","owner_name":"Lewis Karen","owner_display_name":"Lewis Karen","owner_url":"/insider/0001814304","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1632.0,"shares_display":"1,632","price_per_share":66.8086,"price_display":"66.81","price_state":"stated","total_value":109031.6352,"total_display":"109,031.64","total_whole":"109,032","shares_owned_after":56937.0,"shares_owned_after_display":"56,937","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-16","filed_date":"2024-01-17","scope":"insider"},{"id":8675316,"accession":"0001127602-23-017568","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-017568","line_url":"/filing/0001127602-23-017568#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001814304","owner_name":"Lewis Karen","owner_display_name":"Lewis Karen","owner_url":"/insider/0001814304","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":86.0,"price_display":"86.00","price_state":"stated","total_value":430000.0,"total_display":"430,000.00","total_whole":"430,000","shares_owned_after":41504.0,"shares_owned_after_display":"41,504","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-01","filed_date":"2023-06-02","scope":"insider"},{"id":8587302,"accession":"0001127602-23-012595","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-012595","line_url":"/filing/0001127602-23-012595#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001814304","owner_name":"Lewis Karen","owner_display_name":"Lewis Karen","owner_url":"/insider/0001814304","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":75.0,"price_display":"75.00","price_state":"stated","total_value":375000.0,"total_display":"375,000.00","total_whole":"375,000","shares_owned_after":41430.0,"shares_owned_after_display":"41,430","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-03","filed_date":"2023-04-05","scope":"insider"},{"id":8729831,"accession":"0001127602-23-007326","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-23-007326","line_url":"/filing/0001127602-23-007326#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001814304","owner_name":"Lewis Karen","owner_display_name":"Lewis Karen","owner_url":"/insider/0001814304","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1104.0,"shares_display":"1,104","price_per_share":68.76,"price_display":"68.76","price_state":"stated","total_value":75911.04,"total_display":"75,911.04","total_whole":"75,911","shares_owned_after":41430.0,"shares_owned_after_display":"41,430","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-23","filed_date":"2023-02-27","scope":"insider"},{"id":8146954,"accession":"0001127602-23-002750","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-23-002750","line_url":"/filing/0001127602-23-002750#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001814304","owner_name":"Lewis Karen","owner_display_name":"Lewis Karen","owner_url":"/insider/0001814304","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":883.0,"shares_display":"883","price_per_share":52.76,"price_display":"52.76","price_state":"stated","total_value":46587.08,"total_display":"46,587.08","total_whole":"46,587","shares_owned_after":36459.0,"shares_owned_after_display":"36,459","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-30","filed_date":"2023-01-31","scope":"insider"},{"id":7969903,"accession":"0001127602-23-002179","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-23-002179","line_url":"/filing/0001127602-23-002179#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001814304","owner_name":"Lewis Karen","owner_display_name":"Lewis Karen","owner_url":"/insider/0001814304","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2955.0,"shares_display":"2,955","price_per_share":51.58,"price_display":"51.58","price_state":"stated","total_value":152418.9,"total_display":"152,418.90","total_whole":"152,419","shares_owned_after":37709.0,"shares_owned_after_display":"37,709","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-23","filed_date":"2023-01-25","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":15,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001492422","name":"Apellis Pharmaceuticals, Inc.","url":"/issuer/0001492422","role":"Officer (Chief People Officer)","n_filings":14,"first_seen":"2023-01-25","last_seen":"2025-01-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001814304","retrieved_at":"2026-08-25T02:38:05+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}